Skip to main content
Clinical Trials/ISRCTN94728379
ISRCTN94728379
Active, not recruiting
未知

Characterising disease mechanisms in patients with coronary microvascular disease

King's College London0 sites74 target enrollmentJanuary 28, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Coronary microvascular disease
Sponsor
King's College London
Enrollment
74
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 28, 2021
End Date
January 3, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. All adult patients attending for diagnostic coronary angiography for stable angina at St. Thomas’ Hospital who are found to have unobstructed coronary arteries (epicardial coronary artery stenosis \< 30% and/or pressure wire negative stenosis).
  • 2\. Tertiary referrals for invasive microvascular assessment of patients with angina and established unobstructed coronary arteries.

Exclusion Criteria

  • Current exclusion criteria as of 22/05/2023:
  • 1\. Patients who are unable or unwilling to consent
  • 2\. Contraindications to adenosine
  • 3\. Contraindications to amlodipine and/or ranolazine
  • 4\. Patients who are already taking the study medications for clinical reasons and are unable to stop them
  • 5\. Presence of more than moderate valve disease
  • 6\. Previous percutaneous coronary intervention or bypass surgery
  • 7\. Known structural heart disease (e.g. cardiomyopathy or congenital heart disease)
  • 8\. Pregnant or breastfeeding females
  • 9\. Patients who are unable to exercise on a treadmill or those who can exercise for \>540 seconds in the absence of any revealed cardiac symptoms on baseline exercise test

Outcomes

Primary Outcomes

Not specified

Similar Trials